A carregar...
A rare case of synchronous multiple primary lung cancer with different responses to gefitinib
Differentiating multiple primary lung cancer (MPLC) from lung metastasis is important, and the pathology and gene mutations may be different between the tumors. A lung biopsy to differentiate lesions should be considered, especially when the response of different tumors to treatment is distinct.
Na minha lista:
| Publicado no: | Respir Med Case Rep |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7596341/ https://ncbi.nlm.nih.gov/pubmed/33145160 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2020.101270 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|